Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/1993
10/14/1993CA2110283A1 Physiologically active protein and hemotopoietic stem cell growth agent
10/13/1993EP0565511A1 Method of cleaving proteins
10/13/1993EP0565484A2 HIV-protease inhibiting morpholin- and thiomorpholin-4-ylamides
10/13/1993EP0565450A1 Use of peptide derivatives for the manufacture of medicaments inhibiting endopeptidases 24.15 and 24.16
10/13/1993EP0565296A1 Use of melatonin for the manufacture of a medicament for the treatment of benign prostatic hyperplasia
10/13/1993EP0565164A1 Synthetic polypeptides as inhibitors of HIV-1
10/13/1993EP0565148A2 Intermediates for preparation of H-Arg-X-Y-Z-Tyr-R
10/13/1993EP0564972A2 Peptides with N-terminal modifications having bradykinin antagonistic activity
10/13/1993EP0564924A2 2-Oxoethyl derivatives as immunosuppressants
10/13/1993EP0564804A1 Improved high protein liquid nutrition for patients with elevated wound healing requirements
10/13/1993EP0564739A2 Backbone cyclic peptides, processes for their preparation and pharmaceutical compositions containing them
10/13/1993EP0564672A1 Aqueous solution for peritoneal dialysis
10/13/1993EP0564646A1 Trapped cells and use thereof as a drug
10/13/1993EP0564592A1 Liver enriched transcription factor
10/13/1993EP0564561A1 Peptides ketoamides, ketoacids, and ketoesters
10/13/1993EP0564552A1 Use of calpain inhibitors in the inhibition and treatment of neurodegeneration
10/13/1993EP0564533A1 Modified penta- and hexapeptide anaphylatoxin receptor ligands
10/13/1993EP0564502A1 Tissue sealant and growth factor containing compositions that promote accelerated wound healing
10/13/1993EP0564495A1 Tissue factor based prothrombin time reagent
10/13/1993EP0271570B1 Use of mullerian inhibiting substance as a contraceptive agent
10/13/1993CN1077202A Peptide mit modifikationen am n-terminus
10/12/1993US5252725 α-1-antichymotrypsin, analogues and methods of production
10/12/1993US5252718 Fibroblast growth factor antagonists
10/12/1993US5252717 Marek's disease herpesvirus DNA segments encoding glycoproteins, gD, gI and gE
10/12/1993US5252716 Marek's disease herpesvirus DNA segments encoding glycoproteins, gD, gI and gE
10/12/1993US5252715 Process for the preparation of a pasteurized and iron-free human transferrin and the use thereof
10/12/1993US5252713 Polymeric carriers for non-covalent drug conjugation
10/12/1993US5252711 Monoclonal antibodies useful in deodorizing skin and antibody fragments thereof
10/12/1993US5252710 Selective chromatographic separation of Factor VIII from von Willebrand factor; desorption, purification
10/12/1993US5252709 Adjustment of ph of buffer
10/12/1993US5252706 Oligopeptides with protecting groups, a straight-chain or branched alkyl propyl ether; nonleakage
10/12/1993US5252705 Peptide derivatives
10/12/1993US5252566 Antithrombotic agents
10/12/1993US5252560 Cyclic imide derivatives, compositions and use
10/12/1993US5252559 A stimulate mixture of a tripeptides and carrier
10/12/1993US5252558 Pentapeptide having specific inhibiting effect on epidermal cell proliferation, the salts thereof, pharmaceutical compositions comprising the same and a process for the preparation of the pentapeptide and the pharmaceutical compositions
10/12/1993US5252557 With sodium hyaluronate
10/12/1993US5252556 Genetic engineered polypeptide; aids diagnosis
10/12/1993US5252482 Precursor of a C-terminal amidated calcitonin
10/12/1993US5252481 Mutant of bacterium Clostridium histolyticum, a process for the obtaining thereof, and its use in the production of clostripain-free collagenase
10/12/1993US5252480 Human monoclonal antibody and hybridoma producing the same
10/12/1993US5252479 Safe vector for gene therapy
10/12/1993US5252477 Human immunodeficiency virus specific proteolytic enzyme and a method for its synthesis and renaturation
10/12/1993US5252467 Method of making antibodies to antigenic epitopes of IGE present on B cells but not basophil cell surface or secreted, soluble IGE
10/12/1993US5252342 Enhancement of anti-neoplastic drug efficacy using EGF
10/12/1993US5252338 Therapy delayed
10/12/1993US5252217 Blood coagulation factor XI concentrate having high specific activity, suitable for therapeutic use, and process for preparing same
10/12/1993US5252216 Using combination chromatography
10/12/1993CA1323139C Method of producing substantially pure albumin
10/11/1993CA2093575A1 Human antithrombin iii mutant
10/11/1993CA2093453A1 High protein liquid nutrition for patients with elevated wound healing requirements
10/11/1993CA2090377A1 Anti-cancer therapeutic compositions for prophylaxis or for treatment of chemically induced cancer
10/10/1993CA2093753A1 Hexapaptide
10/09/1993CA2093163A1 Method and composition for treating immune disorders, inflammation and chronic infections
10/09/1993CA2091194A1 2-oxo-ethyl derivatives as immunosuppressants
10/07/1993DE4242015A1 Wundverband, Wundauflage oder Trägermatrix Dressing, wound overlay or carrier matrix
10/07/1993CA2092776A1 A method of proteolytically cleaving proteins and the use of said method
10/06/1993EP0564216A2 Pharmaceutical compositions for the treatment and/or prevention of degenerative disorders in the retina
10/06/1993EP0563844A1 Antimicrobial compositions and pharmaceutical preparations thereof
10/06/1993EP0563714A2 TNF-Muteins
10/06/1993EP0563627A2 Anti-tumor method and anti-tumor agent
10/06/1993EP0563487A1 Monoclonal antibodies against the interferon receptor, with neutralizing activity against type I interferon
10/06/1993EP0563475A1 Cell binding agent conjugates of derivatives of CC-1065
10/06/1993EP0563389A1 Pharmaceutical aerosol preparation and its use for treatment and prophylaxis of viral diseases
10/06/1993EP0563385A1 Thrombolytic peptide, production thereof and thrombolytic agent
10/06/1993EP0563383A1 (ganoderma lucidium) iy009 which produces proteoglycan (g009) having effect of enhancing antitumor immunity
10/06/1993EP0563329A1 Angiogenic peptides
10/06/1993EP0563307A1 Medicaments for the treatment of papillomavirus diseases
10/06/1993EP0563304A1 Neuronal cholinergic differentiation factor
10/06/1993EP0563302A1 Method and apparatus for granulation
10/06/1993EP0563244A1 Human phospholipase activating protein and methods for diagnosis of rheumatoid arthritis
10/06/1993EP0563240A1 Lipid receptors for microorganisms and corresponding adhesins, dna sequences encoding adhesins, and use thereof
10/06/1993EP0563239A1 A truncated interleukin-1 receptor gene for the treatment of arthritis
10/06/1993EP0563222A1 Biologically active bactericidal/permeability-increasing protein fragments
10/06/1993EP0563214A1 Bifunctional antibodies and method of preparing same
10/06/1993EP0563212A1 Synthetic immunoactive peptides having immunomodulating and therapeutic activities
10/06/1993EP0563209A1 Use of hirudine and its muteines and their peg derivatives for the combined treatment of tumours
10/06/1993EP0563177A1 Oral administration of alpha interferon to treat lung malignancies
10/06/1993EP0563172A1 Synthetic bioadhesive polypeptide
10/06/1993EP0563093A1 A composition used as a therapeutic agent against chronic viral hepatic diseases
10/06/1993EP0563089A1 Serotonine receptor of class 1: the 5-ht 1x? receptors
10/06/1993EP0563060A1 Synergism of tnf and il-4
10/06/1993EP0556345A4 Retroviral vectors useful for gene therapy
10/06/1993EP0379516B1 Hyper-immune globulin against hiv
10/06/1993EP0356481B1 Purified hemoglobin solutions and method for making same
10/06/1993EP0314749B1 Haemoglobin complexes
10/06/1993CN1076966A Cloning and expression of humanized monoclonal antibodies against human interleukin-4
10/05/1993US5250665 Specifically β-β cross-linked hemoglobins and method of preparation
10/05/1993US5250663 Preparing essentially monomeric normal human serum albumin
10/05/1993US5250662 Precipitation of contaminants in acid solution; binding soluble contaminants to anion-exchange resin; pH adjustment
10/05/1993US5250515 Method for improving the efficacy of insect toxins
10/05/1993US5250514 Method of treating infertility or sub-fertility in adult men, and the use of preparations in the method
10/05/1993US5250513 Antioxidant system based on a basic amino acid in combination with a tocopherol or derivative thereof and a nonthiolated polypeptide, and compositions containing the same
10/05/1993US5250431 Having alteration or deletion in binding site, for reduced binding capability
10/05/1993US5250421 Culturing mammalian cells transfected with DNA expression vector coding in serum free medium containing phospholipid
10/05/1993US5250414 Diagnostic methods using neurite growth regulatory factors
10/05/1993US5250302 A DNA sequence encoding a polypeptide which together with a matrix induces endochondral bone formation in mammals
10/05/1993US5250299 Disinfectant mixture having ph adjusted by di- or tri-carboxylic acid, for treating surfaces of foods or food processing equipment
10/05/1993US5250297 Medical diagnosis, anticarcinogenic agents
10/05/1993US5250296 Immunostimulant agent containing interleukin-2 and 5'-deoxy-5-fluorouridine
1 ... 2920 2921 2922 2923 2924 2925 2926 2927 2928 2929 2930 2931 2932 2933 2934 2935 2936 2937 2938 2939 2940 ... 3163